List of Tables
Summary Table: Global Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 1: Subunit and Recombinant Protein Vaccines
Table 2: DIVA Vaccines
Table 3: Dairy Livestock Infection Category Vaccination
Table 4: Vaccines for Companion Animals
Table 5: Vaccines for Equine Infections
Table 6: Vaccines for Swine Infection
Table 7: Vaccines for Poultry Infection
Table 8: Vaccines for Other Animals Infections
Table 9: Vaccines and Veterinary Medicines Exports, by Country, 2021
Table 10: List of Different Types of Diseases in Animals
Table 11: Number of Outbreaks, Cases and Animal Losses Caused by ASF, 2021
Table 12: Coronavirus Reported Cases and Deaths, by Country, 2020
Table 13: Pipeline Analysis of Animal Vaccines
Table 14: Global Market for Veterinary Vaccines, by Product, Through 2028
Table 15: Global Market for Attenuated Vaccines, Through 2028
Table 16: Global Market for Recombinant Vaccines, Through 2022
Table 17: Veterinary Vaccines in Aquaculture
Table 18: Global Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 19: Global Meat Trade, by Beef and Sheep
Table 20: Global Poultry Trade
Table 21: Global Swine Trade
Table 22: Global Market for Veterinary Vaccines, by Administration, Through 2028
Table 23: Global Market for Veterinary Vaccines, by Region, Through 2028
Table 24: North American Market for Veterinary Vaccines, by Product, Through 2028
Table 25: North American Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 26: North American Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 27: North American Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 28: North American Market for Veterinary Vaccines, by Administration, Through 2028
Table 29: North American Market for Veterinary Vaccines, by Country, Through 2028
Table 30: U.S. Market for Veterinary Vaccines, by Product, Through 2028
Table 31: U.S. Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 32: U.S. Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 33: U.S. Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 34: U.S. Market for Veterinary Vaccines, by Administration, Through 2028
Table 35: United States Pets Vaccine Cost
Table 36: Canadian Market for Veterinary Vaccines, by Product, Through 2028
Table 37: Canadian Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 38: Canadian Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 39: Canadian Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 40: Canadian Market for Veterinary Vaccines, by Administration, Through 2028
Table 41: Flocks Confirmed with Avian Influenza in Canada, 2021
Table 42: Mexican Market for Veterinary Vaccines, by Product, Through 2028
Table 43: Mexican Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 44: Mexican Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 45: Mexican Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 46: Mexican Market for Veterinary Vaccines, by Administration, Through 2028
Table 47: European Market for Veterinary Vaccines, by Product, Through 2028
Table 48: European Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 49: European Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 50: European Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 51: European Market for Veterinary Vaccines, by Administration, Through 2028
Table 52: European Market for Veterinary Vaccines, by Country, Through 2028
Table 53: German Market for Veterinary Vaccines, by Product, Through 2028
Table 54: German Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 55: German Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 56: German Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 57: German Market for Veterinary Vaccines, by Administration, Through 2028
Table 58: Italian Market for Veterinary Vaccines, by Product, Through 2028
Table 59: Italian Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 60: Italian Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 61: Italian Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 62: Italian Market for Veterinary Vaccines, by Administration, Through 2028
Table 63: Number of Enzootic Bovine Leukosis Breakouts in Italy Region, 2011-2020
Table 64: French Market for Veterinary Vaccines, by Product, Through 2028
Table 65: French Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 66: French Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 67: French Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 68: French Market for Veterinary Vaccines, by Administration, Through 2028
Table 69: U.K. Market for Veterinary Vaccines, by Product, Through 2028
Table 70: U.K. Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 71: U.K. Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 72: U.K. Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 73: U.K. Market for Veterinary Vaccines, by Administration, Through 2028
Table 74: Spanish Market for Veterinary Vaccines, by Product, Through 2028
Table 75: Spanish Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 76: Spanish Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 77: Spanish Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 78: Spanish Market for Veterinary Vaccines, by Administration, Through 2028
Table 79: Rest of European Market for Veterinary Vaccines, by Product, Through 2028
Table 80: Rest of European Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 81: Rest of European Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 82: Rest of European Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 83: Rest of European Market for Veterinary Vaccines, by Administration, Through 2028
Table 84: Asia-Pacific Market for Veterinary Vaccines, by Product, Through 2028
Table 85: Asia-Pacific Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 86: Asia-Pacific Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 87: Asia-Pacific Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 88: Asia-Pacific Market for Veterinary Vaccines, by Administration, Through 2028
Table 89: Asia-Pacific Market for Veterinary Vaccines, by Country, Through 2028
Table 90: Japanese Market for Veterinary Vaccines, by Product, Through 2028
Table 91: Japanese Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 92: Japanese Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 93: Japanese Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 94: Japanese Market for Veterinary Vaccines, by Administration, Through 2028
Table 95: Indian Market for Veterinary Vaccines, by Product, Through 2028
Table 96: Indian Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 97: Indian Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 98: Indian Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 99: Indian Market for Veterinary Vaccines, by Administration, Through 2028
Table 100: Australian and New Zealand Market for Veterinary Vaccines, by Product, Through 2028
Table 101: Australian and New Zealand Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 102: Australian and New Zealand Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 103: Australian and New Zealand Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 104: Australian and New Zealand Market for Veterinary Vaccines, by Administration, Through 2028
Table 105: Chinese Market for Veterinary Vaccines, by Product, Through 2028
Table 106: Chinese Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 107: Chinese Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 108: Chinese Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 109: Chinese Market for Veterinary Vaccines, by Administration, Through 2028
Table 110: Rest of Asia-Pacific Market for Veterinary Vaccines, by Product, Through 2028
Table 111: Rest of Asia-Pacific Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 112: Rest of Asia-Pacific Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 113: Rest of Asia-Pacific Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 114: Rest of Asia-Pacific Market for Veterinary Vaccines, by Administration, Through 2028
Table 115: Latin American Market for Veterinary Vaccines, by Product, Through 2028
Table 116: Latin American Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 117: Latin American Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 118: Latin American Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 119: Latin American Market for Veterinary Vaccines, by Administration, Through 2028
Table 120: Latin American Market for Veterinary Vaccines, by Country, Through 2028
Table 121: Brazilian Market for Veterinary Vaccines, by Product, Through 2028
Table 122: Brazilian Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 123: Brazilian Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 124: Brazilian Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 125: Brazilian Market for Veterinary Vaccines, by Administration, Through 2028
Table 126: Argentinian Market for Veterinary Vaccines, by Product, Through 2028
Table 127: Argentinian Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 128: Argentinian Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 129: Argentinian Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 130: Argentinian Market for Veterinary Vaccines, by Administration, Through 2028
Table 131: Argentinian Veterinary Vaccines Importers
Table 132: Rest of Latin American Market for Veterinary Vaccines, by Product, Through 2028
Table 133: Rest of Latin American Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 134: Rest of Latin American Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 135: Rest of Latin American Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 136: Rest of Latin American Market for Veterinary Vaccines, by Administration, Through 2028
Table 137: Middle East & African Market for Veterinary Vaccines, by Product, Through 2028
Table 138: Middle East & African Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 139: Middle East & African Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 140: Middle East & African Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 141: Middle East & African Market for Veterinary Vaccines, by Administration, Through 2028
Table 142: Middle East & African Market for Veterinary Vaccines, by Country, Through 2028
Table 143: Potential Research Collaborations
Table 144: GCC Countries Market for Veterinary Vaccines, by Product, Through 2028
Table 145: GCC Countries Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 146: GCC Countries Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 147: GCC Countries Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 148: GCC Countries Market for Veterinary Vaccines, by Administration, Through 2028
Table 149: South African Market for Veterinary Vaccines, by Product, Through 2028
Table 150: South African Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 151: South African Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 152: South African Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 153: South African Market for Veterinary Vaccines, by Administration, Through 2028
Table 154: Rest of Middle East and African Market for Veterinary Vaccines, by Product, Through 2028
Table 155: Rest of Middle East and African Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 156: Rest of Middle East and African Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 157: Rest of Middle East and African Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 158: Rest of Middle East and African Market for Veterinary Vaccines, by Administration, Through 2028
Table 159: Company Growth Ratio and Income Values
Table 160: SWOT Analysis: Market for Veterinary Vaccines
Table 161: M&A among Animal Healthcare Companies, 2021
Table 162: Startup Funding in Animal Healthcare, January 2022 to March 2023
Table 163: Arko Laboratories: Animal Vaccine Products
Table 164: Avimex: Animal Vaccine Products
Table 165: Avimex: Development and Strategy
Table 166: Boehringer Ingelheim: Annual Revenue, 2022
Table 167: Boehringer Ingelheim: News
Table 168: Boehringer Ingelheim: Animal Vaccine Products
Table 169: Ceva: Annual Revenue, 2022
Table 170: Ceva: News
Table 171: Ceva: Animal Vaccine Products
Table 172: Dechra: Annual Revenue, 2022
Table 173: Dechra: News
Table 174: Dechra: Animal Vaccine Products
Table 175: Annual Revenue, 2022
Table 176: Elanco: News
Table 177: Elanco: Animal Vaccine Products
Table 178: Merck & Co. Inc.: Annual Revenue, 2022
Table 179: Merck & Co. Inc.: News
Table 180: Merck & Co. Inc.: Animal Vaccine Products
Table 181: Phibro Animal Health Corp.: Annual Revenue, 2022
Table 182: Phibro Animal Health Corp.: News
Table 183: Phibro Animal Health Corp.: Animal Vaccine Products
Table 184: Virbac: Annual Revenue, 2021
Table 185: Virbac: News
Table 186: Virbac: Animal Vaccine Products
Table 187: Zoetis Services LLC: Annual Revenue, 2021
Table 188: Zoetis Services LLC: News
Table 189: Zoetis Services LLC: Animal Vaccine Products
List of Figures
Summary Figure: Global Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 1: Top Manufacturers in Animal Health Products
Figure 2: Increase in Livestock Commodity Production, 2020-2030
Figure 3: Pet Populations in Major Regions
Figure 4: Rise in Consumer Spending on Pets, 2016-2021
Figure 5: Comparison of Japan and the U.S. on Animal Life Expectancy
Figure 6: Snapshot of Genes, Single-Nucleotide Polymorphisms (SNPs), and Quantitative Trait Loci (QTL) Related to Cattle Longevity
Figure 7: New Tuberculosis Herd Incidents, Wales, 2022
Figure 8: Animals Slaughtered for TB Control, Wales, 2008-2022
Figure 9: Number of Countries Affected by HPAI, 2005-2021
Figure 10: Worldwide Distribution of SARS-CoV-2 Outbreaks in 23 Animals Species
Figure 11: Factors Affecting Livestock Diseases in African Countries
Figure 12: Drivers of Zoonotic Outbreaks
Figure 13: Livestock Pathogens and Zoonoses
Figure 14: Growing Population of the World
Figure 15: Global Production of Meat and Eggs
Figure 16: Barriers to Animal Vaccination
Figure 17: Modalities for Purchasing Rabies Vaccine from World Vaccine Bank, 2012-2021
Figure 18: Impact of COVID-19 on Pharma Industry
Figure 19: SARS CoV-2 Infections in Non-Human Animals
Figure 20: Impact of COVID-19 on Species Group
Figure 21: Impact of COVID-19 on Species Group, by Country
Figure 22: Impact of COVID-19 on Different Input Issues
Figure 23: Global Animal Disease Cases, 2005-2021
Figure 24: Patent Volumes: Multivalent Veterinary Vaccines
Figure 25: Global Market Shares of Veterinary Vaccines, by Product, 2022
Figure 26: Global Market Shares of Attenuated Vaccines, 2022
Figure 27: Global Market Shares of Recombinant Vaccines, 2022
Figure 28: Global Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 29: Growth of Meat Production, by Region, 2019-2023
Figure 30: Confirmed Cases of SARS-CoV-2 in the U.S., by Type of Animal, 2023
Figure 31: Pet Ownership in Europe, by Type of Animal, 2023
Figure 32: Global Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 33: Global Market Shares of Veterinary Vaccines, by Region, 2022
Figure 34: North American Beef Cattle Inventory, 2000-2022
Figure 35: North American Market Shares of Veterinary Vaccines, by Product, 2022
Figure 36: North American Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 37: North American Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 38: North American Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 39: North American Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 40: North American Market Shares of Veterinary Vaccines, by Country, 2022
Figure 41: U.S. Cattle Inventory
Figure 42: U.S. Market Shares of Veterinary Vaccines, by Product, 2022
Figure 43: U.S. Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 44: U.S. Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 45: U.S. Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 46: U.S. Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 47: Canadian Market Shares of Veterinary Vaccines, by Product, 2022
Figure 48: Canadian Market Shares of Veterinary Vaccines, by Attenuated Vaccine, 2022
Figure 49: Canadian Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 50: Canadian Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 51: Canadian Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 52: Mexican Market Shares of Veterinary Vaccines, by Product, 2022
Figure 53: Mexican Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 54: Mexican Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 55: Mexican Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 56: Mexican Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 57: European Market Shares of Veterinary Vaccines, by Product, 2022
Figure 58: European Market Shares of Veterinary Vaccines, by Attenuated Vaccine, 2022
Figure 59: European Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 60: European Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 61: European Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 62: European Market Shares of Veterinary Vaccines, by Country, 2022
Figure 63: German Market Shares of Veterinary Vaccines, by Product, 2022
Figure 64: German Market Shares of Veterinary Vaccines, by Attenuated Vaccine, 2022
Figure 65: German Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 66: German Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 67: German Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 68: Italian Market Shares of Veterinary Vaccines, by Product, 2022
Figure 69: Italian Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 70: Italian Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 71: Italian Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 72: Italian Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 73: French Market Shares of Veterinary Vaccines, by Product, 2022
Figure 74: French Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 75: French Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 76: French Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 77: French Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 78: U.K. Market Shares of Veterinary Vaccines, by Product, 2022
Figure 79: U.K. Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 80: U.K. Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 81: U.K. Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 82: U.K. Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 83: Spanish Market Shares of Veterinary Vaccines, by Product, 2022
Figure 84: Spanish Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 85: Spanish Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 86: Spanish Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 87: Spanish Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 88: Rest of European Market Shares of Veterinary Vaccines, by Product, 2022
Figure 89: Rest of European Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 90: Rest of European Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 91: Rest of European Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 92: Rest of European Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 93: Growing Consumer Spending on Companion Animals
Figure 94: Asia-Pacific Market Shares of Veterinary Vaccines, by Product, 2022
Figure 95: Asia-Pacific Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 96: Asia-Pacific Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 97: Asia-Pacific Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 98: Asia-Pacific Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 99: Asia-Pacific Market Shares of Veterinary Vaccines, by Country, 2022
Figure 100: Japanese Market Shares of Veterinary Vaccines, by Product, 2022
Figure 101: Japanese Market Shares of Veterinary Vaccines, by Attenuated Vaccine, 2022
Figure 102: Japanese Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 103: Japanese Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 104: Japanese Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 105: Japanese Cat and Dog Ownership
Figure 106: Indian Market Shares of Veterinary Vaccines, by Product, 2022
Figure 107: Indian Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 108: Indian Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 109: Indian Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 110: Indian Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 111: Australian and New Zealand Market Shares of Veterinary Vaccines, by Product, 2022
Figure 112: Australian and New Zealand Market Shares of Veterinary Vaccines, by Attenuated Vaccine, 2022
Figure 113: Australian and New Zealand Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 114: Australian and New Zealand Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 115: Australian and New Zealand Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 116: Chinese Market Shares of Veterinary Vaccines, by Product, 2022
Figure 117: Chinese Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 118: Chinese Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 119: Chinese Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 120: Chinese Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 121: Rest of Asia-Pacific Market Shares of Veterinary Vaccines, by Product, 2022
Figure 122: Rest of Asia-Pacific Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 123: Rest of Asia-Pacific Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 124: Rest of Asia-Pacific Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 125: Rest of Asia-Pacific Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 126: Latin American Market Shares of Veterinary Vaccines, by Product, 2022
Figure 127: Latin American Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 128: Latin American Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 129: Latin American Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 130: Latin American Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 131: Latin American Market Shares of Veterinary Vaccines, by Country, 2022
Figure 132: Brazilian Market Shares of Veterinary Vaccines, by Product, 2022
Figure 133: Brazilian Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 134: Brazilian Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 135: Brazilian Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 136: Brazilian Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 137: Argentinian Market Shares of Veterinary Vaccines, by Product, 2022
Figure 138: Argentinian Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 139: Argentinian Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 140: Argentinian Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 141: Argentinian Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 142: Number of Beef Cattle Vaccinated Against Foot-and-Mouth Disease in Argentina, 2018, by Province
Figure 143: Rest of Latin American Market Shares of Veterinary Vaccines, by Product, 2022
Figure 144: Rest of Latin American Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 145: Rest of Latin American Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 146: Rest of Latin American Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 147: Rest of Latin American Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 148: Middle East & African Market Shares of Veterinary Vaccines, by Product, 2022
Figure 149: Middle East & African Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 150: Middle East & African Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 151: Middle East & African Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 152: Middle East & African Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 153: Middle East & African Market Shares of Veterinary Vaccines, by Country, 2022
Figure 154: GCC Countries Market Shares of Veterinary Vaccines, by Product, 2022
Figure 155: GCC Countries Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 156: GCC Countries Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 157: GCC Countries Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 158: GCC Countries Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 159: South African Market Shares of Veterinary Vaccines, by Product, 2022
Figure 160: South African Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 161: South African Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 162: South African Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 163: South African Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 164: Rest of Middle East and African Market Shares of Veterinary Vaccines, by Product, 2022
Figure 165: Rest of the Middle East and African Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 166: Rest of Middle East and African Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 167: Rest of Middle East and African Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 168: Rest of Middle East and African Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 169: Global Market Shares of Veterinary Vaccines, by Company, 2022
Figure 170: Top Animal Health Mergers and Acquisitions Worldwide, 2014-2018, by Enterprise Value
Figure 171: M&A among Animal Healthcare Companies Deals in 2021
Figure 172: Healthier Animals: A Solution To Significant Global Challenges
Figure 173: ESG Risk Rating of Top Companies
Figure 174: Boehringer Ingelheim: Annual Revenue, 2021 and 2022
Figure 175: Boehringer Ingelheim: Revenue Shares, by Business Unit, 2022
Figure 176: Boehringer Ingelheim: Revenue Shares, by Country/Region, 2022
Figure 177: Ceva: Annual Revenue, 2021-2022
Figure 178: Dechra: Annual Revenue, 2021 and 2022
Figure 179: Dechra: Revenue Shares, by Business Unit, 2022
Figure 180: Dechra: Revenue Shares, by Country/Region, 2022
Figure 181: Elanco: Annual Revenue, 2021 and 2022
Figure 182: Elanco: Revenue Shares, by Business Unit, 2022
Figure 183: Elanco: Revenue Shares, by Country/Region, 2022
Figure 184: Merck & Co. Inc.: Annual Revenue, 2021 and 2022
Figure 185: Merck & Co. Inc.: Revenue Shares, by Business Unit, 2022
Figure 186: Merck & Co. Inc.: Revenue Shares, by Country/Region, 2022
Figure 187: Phibro Animal Health Corp.: Annual Revenue, 2021 and 2022
Figure 188: Phibro Animal Health Corp.: Revenue Shares, by Business Unit, 2022
Figure 189: Phibro Animal Health Corp.: Revenue Shares, by Country/Region, 2022
Figure 190: Virbac: Annual Revenue, 2020 and 2021
Figure 191: Virbac: Revenue Shares, by Business Unit, 2022
Figure 192: Zoetis Services LLC: Annual Revenue, 2020 and 2021
Figure 193: Zoetis Services LLC: Revenue Shares, by Business Unit, 2022
Figure 194: Zoetis Services LLC: Revenue Shares, by Country/Region, 2022
